• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Richard L. Rauck, Lowell W. Reynolds, +5 authors Larry Dillaha
  • Medicine
  • Current medical research and opinion
  • 2012 (First Publication: 5 April 2012)
  • Abstract Background and objectives: A number of transmucosal fentanyl formulations have been developed for the management of breakthrough cancer pain (BTCP). Sublingual delivery of fentanyl,Expand
  • Jeff Patrick, Larry Dillaha, Danielle Armas, William C. Sessa
  • Medicine
  • Postgraduate medicine
  • 2015 (First Publication: 29 July 2015)
  • Abstract Aims. Low-dose acetylsalicylic acid (ASA; aspirin) for secondary prevention reduces cardiovascular disease mortality risk. ASA acetylates cyclooxygenase in the portal circulation and isExpand
  • Neha J. Parikh, Venkat R. Goskonda, Ashok J. Chavan, Larry Dillaha
  • Medicine
  • Clinical therapeutics
  • 2013 (First Publication: 1 March 2013)
  • BACKGROUND Fentanyl sublingual spray (FSS) is a novel fentanyl formulation recently developed for the treatment of breakthrough cancer pain, which is characterized by a fast onset and a relativelyExpand
  • Srinivas Nalamachu, Neha J. Parikh, Larry Dillaha, Richard L. Rauck
  • Medicine
  • Journal of opioid management
  • 2014 (First Publication: 1 July 2014)
  • OBJECTIVE To examine the relationship between the dose of fentanyl sublingual spray needed to control breakthrough cancer pain (BTCP) and the dose of around-the-clock (ATC) opioid used to controlExpand
  • Richard L. Rauck, Neha J. Parikh, Larry Dillaha, Jerry Barker, Lisa Jo Stearns
  • Medicine
  • Pain practice : the official journal of World…
  • 2015 (First Publication: 1 July 2015)
  • OBJECTIVES Breakthrough cancer pain (BTCP) is associated with decreased satisfaction with around-the-clock opioid therapy. This analysis examined patient satisfaction with fentanyl sublingual sprayExpand
  • Richard L. Rauck, Janet H Bull, Neha J. Parikh, Larry Dillaha, Lisa Jo Stearns
  • Medicine
  • Pain practice : the official journal of World…
  • 2016 (First Publication: 1 November 2016)
  • OBJECTIVE To further describe effective dose titration of fentanyl sublingual spray to treat breakthrough cancer pain (BTCP) during the 26-day open-label titration phase of a phase 3, randomized,Expand